| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5693744 | The Breast | 2017 | 7 Pages |
Abstract
LMA is a prognostic factor for OS and TNT in metastatic breast cancer patients receiving first-line palliative chemotherapy, whereas LMM and sarcopenic obesity are not. Further research is needed to establish what impact LMA should have in daily clinical practice.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Hánah N. Rier, Agnes Jager, Stefan Sleijfer, Joost van Rosmalen, Marc C.J.M. Kock, Mark-David Levin,